Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.68 USD | -2.00% | +1.49% | -40.11% |
Sales 2024 * | - | Sales 2025 * | 10M 13.67M | Capitalization | 402M 550M |
---|---|---|---|---|---|
Net income 2024 * | -66M -90.22M | Net income 2025 * | -81M -111M | EV / Sales 2024 * | - |
Net cash position 2024 * | 316M 432M | Net cash position 2025 * | 437M 597M | EV / Sales 2025 * | -3.47 x |
P/E ratio 2024 * |
-5.32
x | P/E ratio 2025 * |
-5.12
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.73% |
Latest transcript on Tourmaline Bio, Inc.
1 day | -2.00% | ||
1 week | +1.49% | ||
Current month | -31.53% | ||
1 month | -34.17% | ||
3 months | -57.29% | ||
6 months | +19.88% | ||
Current year | -40.11% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 18 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 15.68 | -2.00% | 360,260 |
24-04-25 | 16 | +3.83% | 448,894 |
24-04-24 | 15.41 | +2.12% | 1,779,190 |
24-04-23 | 15.09 | -2.65% | 374,283 |
24-04-22 | 15.5 | +0.32% | 754,803 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.11% | 402M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- TRML Stock